EFFECT OF PELVIC LEAD SHIELD ON ORGAN DOSES IN POSTERO-ANTERIOR CHEST RADIOGRAPHY.


Journal

Radiation protection dosimetry
ISSN: 1742-3406
Titre abrégé: Radiat Prot Dosimetry
Pays: England
ID NLM: 8109958

Informations de publication

Date de publication:
04 Jan 2023
Historique:
received: 02 11 2021
revised: 12 09 2022
accepted: 27 09 2022
pubmed: 9 11 2022
medline: 11 1 2023
entrez: 8 11 2022
Statut: ppublish

Résumé

Lead shields are commonly used in X-ray imaging to protect radiosensitive organs and to minimise patient's radiation dose. However, they might also complicate or interfere with the examination, and even decrease the diagnostic value if they are positioned incorrectly. In this study, the radiation dose effect of waist half-apron lead shield was examined via Monte Carlo simulations of postero-anterior (PA) chest radiography examinations using a female anthropomorphic phantom. Relevant organs for dose determination were lungs, breasts, liver, kidneys and uterus. The organ dose reductions varied depending on shield position and organ but were negligible for properly positioned shields. The shield that had the largest effective dose reduction (9%) was partly positioned inside the field of view, which should not be done in practice. Dose reduction was practically 0% for properly positioned shields. Therefore, the use of lead shield in the pelvic region during chest PA examinations should be discontinued.

Identifiants

pubmed: 36347420
pii: 6809963
doi: 10.1093/rpd/ncac216
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-34

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Anna Kelaranta (A)

HUS Medical Imaging Center, University of Helsinki and Helsinki University Hospital, FI-00290 Helsinki, Finland.
Department of Physics, University of Helsinki, FI-00014 Helsinki, Finland.
Suomen Terveystalo Ltd, Jaakonkatu 3A, FI-00100 Helsinki, Finland.

Teemu Mäkelä (T)

HUS Medical Imaging Center, University of Helsinki and Helsinki University Hospital, FI-00290 Helsinki, Finland.
Department of Physics, University of Helsinki, FI-00014 Helsinki, Finland.

Teemu Hyppänen (T)

HUS Medical Imaging Center, University of Helsinki and Helsinki University Hospital, FI-00290 Helsinki, Finland.

Paula Toroi (P)

STUK-Radiation and Nuclear Safety Authority, Jokiniemenkuja 1, FI-01370 Vantaa, Finland.

Mika Kortesniemi (M)

HUS Medical Imaging Center, University of Helsinki and Helsinki University Hospital, FI-00290 Helsinki, Finland.
Department of Physics, University of Helsinki, FI-00014 Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH